AI’s next pharma challenge: tackling costly and risky clinical trials

Agentic AI in production: Merck, Mastercard on what works

Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes. Both say infrastructure came first.